Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
|
IN |
|
R
|
Ryanair Holdings PLC
F:RY4C
|
IE |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
Wall St Price Targets
AKUMS Price Targets Summary
Akums Drugs and Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for AKUMS is 703.8 INR with a low forecast of 616.1 INR and a high forecast of 819 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKUMS's stock price target?
Price Target
703.8
INR
According to Wall Street analysts, the average 1-year price target for AKUMS is 703.8 INR with a low forecast of 616.1 INR and a high forecast of 819 INR.
What is the Revenue forecast for Akums Drugs and Pharmaceuticals Ltd?
Projected CAGR
13%
Over the last 1 year, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 4 years is 13%.
What is the Gross Profit forecast for Akums Drugs and Pharmaceuticals Ltd?
Projected CAGR
17%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 17%.
What is the Operating Income forecast for Akums Drugs and Pharmaceuticals Ltd?
Projected CAGR
27%
Over the last 1 year, the compound annual growth rate for Operating Income has been -13%. The projected CAGR for the next 4 years is 27%.
What is the Pre-Tax Income forecast for Akums Drugs and Pharmaceuticals Ltd?
Projected CAGR
26%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 26%.
What is the Net Income forecast for Akums Drugs and Pharmaceuticals Ltd?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 4 years is 18%.
